Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registries
about
Respiratory Syncytial Virus Infection in High-risk Infants - an Update on Palivizumab ProphylaxisRespiratory infections in children up to two years of age on prophylaxis with palivizumab.Respiratory Syncytial Virus Related Readmission in Preterm Infants Less than 34 weeks' Gestation Following Discharge from a Neonatal Intensive Care Unit in Korea.First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005-2015).Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention.Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis.Value of a risk scoring tool to predict respiratory syncytial virus disease severity and need for hospitalization in term infants.Immunoprophylaxis against respiratory syncytial virus with palvizumab: what is new?Impact of the use of immunoglobulin palivizumab in the State of São Paulo: a cohort study 1.Effectiveness of palivizumab immunoprophylaxis in preterm infants against respiratory syncytial virus disease in Qatar.Letters to the Editor.Respiratory syncytial virus hospitalization and incurred morbidities the season after prophylaxis
P2860
Q34049590-18F04ECF-DA92-4449-9B82-C5736367F59CQ34279488-26972E42-DFEF-44E8-BFDC-CED261DA0E3DQ36269402-D2F14356-BBF5-4292-80A2-7A25E5E0A652Q37660572-699D0643-5CE6-4EC3-82CB-F5B4FD65B9D9Q38604949-2B813F80-556C-4BAE-AB7D-DF84D535462DQ39025676-1F8CBCF8-9535-4C3D-98FE-DEC566336D2FQ41199983-ED1E5547-0B24-425F-977E-FAE8AA3976A9Q42905961-908ECABD-40D4-4F6A-B78A-747AD6914C38Q47132154-D80136FF-9411-4D8D-9639-F1D24AF3CCF5Q49474232-3317C3C8-FE12-4BB9-BDED-208108E2FD01Q51558042-0B09FD0C-E5EE-43C1-AB20-A787319EC98CQ58084597-D287455F-A0B1-40D7-8A88-AE5CA13FBAC8
P2860
Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registries
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Respiratory-related hospitaliz ...... other international registries
@en
type
label
Respiratory-related hospitaliz ...... other international registries
@en
prefLabel
Respiratory-related hospitaliz ...... other international registries
@en
P2093
P2860
P356
P1476
Respiratory-related hospitaliz ...... other international registries
@en
P2093
Bosco Paes
Tetsuhiro Harimoto
P2860
P304
P356
10.1155/2013/917068
P577
2013-06-19T00:00:00Z